Galantamine: its use in Alzheimer's
  Galantamine is an effective treatment for Alzheimer's which improves cognition, function and activities of daily living in the short term in patients with Alzheimer's disease. continue

Galantamine: a new treatment for Alzheimer's
  Galantamine produces beneficial effects even after it has been terminated. continue

Galantamine: benefits to Alzheimer's patients
  Galantamine was found to be significantly superior to placebo in all five studies continue

Galantamine: in Alzheimer's patients
Galantamine slowed the decline of functional ability in Alzheimer's disease continue

Galantamine: its effects on Alzheimer's 
Galantamine modulates nicotinic receptors in Alzheimer's disease  continue

Galantamine: a study in Alzheimer's
Galantamine 16 and 24 mg/day significantly benefits the cognitive, functional, and behavioral symptoms of Alzheimer's disease as compared with placebo. continue

Galantamine: efficacy of galantamine in dementia and Alzheimer's disease
  Galantamine has shown benefits in patients with Alzheimer's disease  continue

Galantamine: for Alzheimer's disease
  Galantamine is a modulator at nicotinic cholinergic receptor sites   continue

Galantamine: facilitates synaptic transmission in the central nervous system
  Galantamine, a cholinesterase inhibitor and a nicotinic potentiating  continue

Galantamine: new developments in the treatment of Alzheimer's disease
  Galantamine inhibits acetylcholinesterase and modulates nicotinic receptors continue 

Galantamine: novel approach to the treatment of Alzheimer disease
  Galantamine has shown to improve cognitive function for at least 6 months  continue 

Galantamine: maintaining cognitive function in Alzheimer disease
  Galantamine inhibits AChE and modulates cholinergic nicotinic receptors continue 

Galantamine: maintaining functional abilities in Alzheimer disease
  Galantamine showed evidence of functional benefit in three studies continue 

Galantamine: a new Alzheimer drug with a past life
  Galantamine acts as both an AChE inhibitor and a nicotinic receptor agonist. continue 

Galantamine: the rationale for treating vascular dementia with galantamine
  There is evidence that the cholinergic system is impaired in vascular dementia continue

Galantamine: rationale for switching from donepezil to galantamine
  Galantamine is an attractive option for patients with Alzheimer's disease who have not benefited from their current therapy. Methods for switching patients from donepezil continue

Galantamine: switching previous therapies for Alzheimer's disease to galantamine
  Acetylcholinesterase inhibitors are the most frequently used drugs for Alzheimer's continue

Galantamine: effects of galantamine in patients previously treated with donepezil
  Three clinical trials have been designed to provide data that will assist in the determination of the optimal conditions for switching patients from donepezil to galantamine continue

Galantamine: a six month Alzheimer's study
Galantamine is effective and safe in Alzheimer's disease. Galantamine significantly improved cognition and daily function was maintained for 12 months   continue

Galantamine: therapeutic effects beyond cognition
Galantamine-treated patients had a significantly better outcome than placebo-treated patients, and after 12 months of treatment   continue

Galantamine: acetylcholinesterase inhibition
  Evidence suggests galanthamine to be similar to other acetylcholinesterase inhibitors in improving cognitive function in Alzheimer's disease patients. continue

Galantamine: nicotinic receptors in Alzheimer's
Galantamine maintains patients' level of cognitive and daily function for at least 1 year, which has not been reported for other acetylcholinesterase inhibitors. continue

Galantamine: effect on nicotinic receptor binding
Galantamine can increase the density of nicotinic receptors in brain regions that are involved in memory. The benefits produced by Galantamine in Alzheimer's  continue

Galantamine: an allosterically potentiating ligant
  Galantamine is a novel drug treatment for mild to moderate Alzheimer's disease. continue

Galantamine: nicotinic modulation in older rabbits
Galantamine may be effective as a cognition-enhancer in Alzheimer's disease. continue

Galantamine: effect on memory & nicotinic receptors
  Effects of galantamine on memory and nicotinic receptors in old rats. continue

Galantamine: profiles of current therapies for Alzheimer's
  Galantamine differs from other cholinesterase inhibitors  continue

Galantamine: safety in Japanese and Caucasians   continue

Galantamine: ameliorates early signs of neurodegeneration   continue

Galantamine: dual mode of action for Alzheimer's
  Galantamine is the only Alzheimer's drug that modulates nicotinic receptors   continue

Galantamine: economic analysis of galantamine in Alzheimer's   continue

Galantamine: cost of Alzheimer's treatment    continue

Galantamine: switching cholinesterase inhibitors in Alzheimer's   continue

Galantamine: nicotinic receptors, galantamine and Alzheimer's   continue

Galantamine: provides benefits for Alzheimer's for up to six months   continue

Galantamine side effects - Nausea, diarrhea, stomach pain, indigestion, weight loss. 
If side effects are experienced, reduce the dosage and build up to the recommended dosage